Periodontal disease — chronic bacterial infection of the gums and supporting structures of the teeth — affects nearly half of adults over 30 in the United States and is causally linked to cardiovascular disease, type 2 diabetes, adverse pregnancy outcomes, and Alzheimer's disease. The mouth is not isolated from the rest of the body. Oral inflammation and the bacteria that drive it have systemic consequences that are increasingly well-documented and mechanistically understood.
The compartmentalization of medicine into specialties has produced a practical problem for patient care: oral health is managed by dentists, cardiovascular health by cardiologists, metabolic health by endocrinologists, and neurological health by neurologists — with limited communication between these silos. The biology does not respect these boundaries. The chronic bacterial infection that produces bleeding gums and pocket formation in the mouth generates a systemic inflammatory load and bacterial translocation with consequences in the coronary arteries, brain, and metabolic organs that are increasingly well-documented.1
Periodontal disease is a chronic inflammatory condition driven by the accumulation of a dysbiotic oral biofilm (dental plaque) that, when not adequately disrupted by brushing and flossing, matures into a community dominated by anaerobic gram-negative bacteria — particularly Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia (the "red complex" pathogens). This biofilm triggers a host inflammatory response designed to clear the bacterial challenge, but the chronic nature of inadequately treated periodontal disease means this inflammatory response becomes persistent and self-amplifying, producing the progressive destruction of the periodontal ligament and alveolar bone that characterizes advanced periodontitis.2
Gingivitis (superficial gum inflammation with bleeding but no bone loss) affects approximately 50 percent of adults in the United States. Periodontitis (with attachment loss and bone destruction) affects approximately 42 percent of adults and 60 percent of adults over 65. The transition from gingivitis to periodontitis is not inevitable — it is driven by the adequacy of oral hygiene, the virulence of the oral microbiome, and host susceptibility factors including smoking, diabetes, and genetics.
The oral-cardiovascular link operates through several converging mechanisms. The periodontal pocket — the gap between tooth and gum that deepens in periodontitis — provides an ulcerated epithelial surface through which bacteria and their products directly enter the bloodstream. This oral bacteremia occurs with every chewing episode in people with untreated periodontitis, producing repeated exposure of the vascular endothelium to periodontal pathogens and their lipopolysaccharides.3
P. gingivalis specifically has been found to penetrate coronary artery endothelial cells, promote foam cell formation from macrophages, and accelerate atherosclerotic plaque development in animal models. Mendelian randomization studies using genetic instruments for periodontal disease susceptibility have found causal associations with coronary artery disease independent of shared confounders including smoking, diet, and socioeconomic status. A 2018 meta-analysis found that adults with periodontal disease had approximately 25 percent higher cardiovascular mortality than those without.
Among the emerging connections between periodontal disease and systemic pathology, the Alzheimer's disease link is perhaps the most striking. A 2019 paper in Science Advances by Dominy et al. reported the detection of P. gingivalis and gingipains (cysteine proteases secreted by P. gingivalis) in the brains of Alzheimer's disease patients at significantly higher concentrations than in age-matched controls. In animal models, oral infection with P. gingivalis produced brain colonization, tau hyperphosphorylation, and amyloid production — the pathological hallmarks of Alzheimer's disease. A gingipain inhibitor (COR388, now atuzaginstat) has entered clinical trials as a potential Alzheimer's therapeutic.4
Causality has not been established — it remains unclear whether P. gingivalis causes Alzheimer's pathology or colonizes the already-compromised brains of Alzheimer's patients (or both). But the finding that a treatable chronic oral infection may contribute to the most feared neurodegenerative disease has transformed how longevity-oriented physicians think about dental care.
Periodontal disease prevention is one of the most straightforward and cost-effective longevity interventions available. Brushing: Twice daily with a soft-bristled electric toothbrush (oscillating-rotating or sonic designs are more effective than manual brushing for plaque removal in studies). Flossing: Once daily — the most commonly neglected element of oral hygiene and the one most critical for interproximal (between-tooth) plaque disruption where periodontal disease typically begins. Interdental brushes are more effective than string floss for wider spaces. Professional care: Professional scaling and polishing every 6 months removes the calcified plaque (calculus/tartar) that cannot be removed by home hygiene and allows early identification and treatment of developing periodontitis.5
